<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005232</url>
  </required_header>
  <id_info>
    <org_study_id>1112</org_study_id>
    <secondary_id>R01HL040397</secondary_id>
    <nct_id>NCT00005232</nct_id>
  </id_info>
  <brief_title>Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>National Heart, Lung, and Blood Institute (NHLBI)</source>
  <brief_summary>
    <textblock>
      To conduct a five-year follow-up of the population of Gubbio, a town in north central Italy,&#xD;
      in order to determine the relationship of baseline sodium-stimulated lithium countertransport&#xD;
      to subsequent change in blood pressure and incidence of hypertension.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:&#xD;
&#xD;
      The field work of the baseline or prevalence phase of the Gubbio Study on the Epidemiology of&#xD;
      Hypertension was conducted between March 1983 and December 1985. The population sample&#xD;
      included all individuals age 5 and over residing in the town of Gubbio. The survey involved a&#xD;
      standardized comprehensive examination focussed on traits previously shown to be related to&#xD;
      hypertensive and/or other adult cardiovascular diseases, and on other traits of current&#xD;
      concern as possible risk factors. This latter category included measurement of red blood cell&#xD;
      electrolyte concentrations and fluxes, particularly sodium-stimulated lithium&#xD;
      countertransport. The study was planned, organized, and conducted by the Merck, Sharp and&#xD;
      Dohme Center for Epidemiologic Research in cooperation with Gubbio civic and medical leaders,&#xD;
      and with laboratory facilities in Gubbio, Naples, and Rome.&#xD;
&#xD;
      Follow-up examinations were conducted in the Centro di Medicina Preventiva in Gubbio which&#xD;
      was furnished and equipped by Merck, Sharp and Dohme of Rome, Italy. Additional work was&#xD;
      conducted at the Center for Epidemiologic Research of Merck, Sharp and Dohme in Rome, at the&#xD;
      University of Naples, and at Northwestern University in Chicago.&#xD;
&#xD;
      DESIGN NARRATIVE:&#xD;
&#xD;
      This prospective study re-examined the 5,500 residents of Gubbio who took part in the Gubbio&#xD;
      Population Study in 1983-1985. The data collected on follow-up focused mainly on factors&#xD;
      related to change in blood pressure and development of hypertension and included standard&#xD;
      physical examination, height, weight, girth, blood pressure, medical history and family&#xD;
      medical history, urine collection for study of electrolyte excretion, venipuncture, 12-lead&#xD;
      electrocardiogram, m-mode echocardiogram, pulse, skinfold measurement, carbon monoxide&#xD;
      content of exhaled breath, sociodemographic data on age, marital status, education, and&#xD;
      employment, and life style data on diet, alcohol intake, smoking, and physical activity.&#xD;
&#xD;
      Measurements made at baseline permitted assessment of whether the hypothesized positive&#xD;
      relation of lithium countertransport to blood pressure was independent of such factors as&#xD;
      age, sex, body mass index, alcohol intake, plasma uric acid, glucose, family history, and&#xD;
      other variables generally associated with blood pressure. The relationship between 5-year&#xD;
      changes in these factors, change in lithium countertransport, and in blood pressure were also&#xD;
      examined. Several additional important unresolved questions on the epidemiology of blood&#xD;
      pressure and hypertension were explored: the role of macronutrients and micronutrients in&#xD;
      lithium countertransport and its change; red blood cell sodium and potassium concentrations&#xD;
      and their relation to blood pressure; possible differences in calcium metabolism between&#xD;
      hypertensives and normotensives; genetic polymorphisms related to lipid-lipoprotein&#xD;
      metabolism and possible influence on blood pressure; patterns of blood pressure change in the&#xD;
      elderly, the 639 and 341 persons age 65-74 and over 75, respectively, at baseline. Coronary&#xD;
      heart disease incidence was also studied.&#xD;
&#xD;
      The study completion date listed in this record was obtained from the &quot;End Date&quot; entered in&#xD;
      the Protocol Registration and Results System (PRS) record.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 1988</start_date>
  <completion_date type="Actual">July 1993</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Cardiovascular Diseases</condition>
  <condition>Heart Diseases</condition>
  <condition>Hypertension</condition>
  <condition>Coronary Disease</condition>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Cirillo M, Laurenzi M. Erythrocyte and platelet volume in human hypertension. The Gubbio Study Collaborative Group. J Hypertens Suppl. 1989 Dec;7(6):S168-9. doi: 10.1097/00004872-198900076-00080.</citation>
    <PMID>2632707</PMID>
  </reference>
  <reference>
    <citation>Laurenzi M, Trevisan M. Sodium-lithium countertransport and blood pressure: the Gubbio Population Study. Hypertension. 1989 May;13(5):408-15. doi: 10.1161/01.hyp.13.5.408.</citation>
    <PMID>2722223</PMID>
  </reference>
  <reference>
    <citation>Cirillo M, Laurenzi M, Stamler J. Factors related to blood pressure in a sample of Italian children age 5 to 14: the Gubbio Population Study. Semin Nephrol. 1989 Sep;9(3):267-71. No abstract available. Erratum In: Semin Nephrol 1990 May;10(3):305.</citation>
    <PMID>2781198</PMID>
  </reference>
  <reference>
    <citation>Laurenzi M, Stamler R, Trevisan M, Dyer A, Stamler J. Is Italy losing the &quot;Mediterranean advantage?&quot; Report on the Gubbio population study: cardiovascular risk factors at baseline. Gubbio Collaborative Study Group. Prev Med. 1989 Jan;18(1):35-44. doi: 10.1016/0091-7435(89)90052-2.</citation>
    <PMID>2710761</PMID>
  </reference>
  <reference>
    <citation>Laurenzi M, Mancini M, Menotti A, Stamler J, Stamler R, Trevisan M, Zanchetti A. Multiple risk factors in hypertension: results from the Gubbio study. J Hypertens Suppl. 1990 Mar;8(1):S7-12. doi: 10.1097/00004872-199003001-00003.</citation>
    <PMID>2332817</PMID>
  </reference>
  <reference>
    <citation>Cirillo M, Laurenzi M, Trevisan M, Stamler J. Hematocrit, blood pressure, and hypertension. The Gubbio Population Study. Hypertension. 1992 Sep;20(3):319-26. doi: 10.1161/01.hyp.20.3.319.</citation>
    <PMID>1516951</PMID>
  </reference>
  <reference>
    <citation>Laurenzi M, Cirillo M, Trevisan M. The Gubbio data. Epidemiology and pathophysiology. Gubbio Study Research Group. Clin Exp Hypertens A. 1992;14(1-2):261-9. doi: 10.3109/10641969209036187.</citation>
    <PMID>1541040</PMID>
  </reference>
  <reference>
    <citation>Trevisan M, Laurenzi M. Correlates of sodium-lithium countertransport. Findings from the Gubbio Epidemiological Study. The Gubbio Collaborative Study Group. Circulation. 1991 Nov;84(5):2011-9. doi: 10.1161/01.cir.84.5.2011.</citation>
    <PMID>1934375</PMID>
  </reference>
  <reference>
    <citation>Trevisan M, Krogh V, Cirillo M, Laurenzi M, Dyer A, Stamler J. Red blood cell sodium and potassium concentration and blood pressure. The Gubbio Population Study. Ann Epidemiol. 1995 Jan;5(1):44-51. doi: 10.1016/1047-2797(94)00040-z.</citation>
    <PMID>7728284</PMID>
  </reference>
  <reference>
    <citation>Strazzullo P, Cappuccio FP. Hypertension and kidney stones: hypotheses and implications. Semin Nephrol. 1995 Nov;15(6):519-25.</citation>
    <PMID>8588112</PMID>
  </reference>
  <reference>
    <citation>Cirillo M, Laurenzi M, Panarelli W, Stamler J. Urinary sodium to potassium ratio and urinary stone disease. The Gubbio Population Study Research Group. Kidney Int. 1994 Oct;46(4):1133-9. doi: 10.1038/ki.1994.376.</citation>
    <PMID>7861708</PMID>
  </reference>
  <reference>
    <citation>Schork NJ, Weder AB, Trevisan M, Laurenzi M. The contribution of pleiotropy to blood pressure and body-mass index variation: the Gubbio Study. Am J Hum Genet. 1994 Feb;54(2):361-73.</citation>
    <PMID>8304351</PMID>
  </reference>
  <reference>
    <citation>Zanchetti A. Concepts of multiple risk factors management: the Gubbio study. J Hypertens Suppl. 1990 Mar;8(1):S3-5. doi: 10.1097/00004872-199003001-00002.</citation>
    <PMID>2332815</PMID>
  </reference>
  <reference>
    <citation>Cirillo M, Laurenzi M, Panarelli W, Trevisan M, Stamler J. Prospective analysis of traits related to 6-year change in sodium-lithium countertransport. Gubbio Population Study Research Group. Hypertension. 1999 Mar;33(3):887-93. doi: 10.1161/01.hyp.33.3.887.</citation>
    <PMID>10082504</PMID>
  </reference>
  <reference>
    <citation>Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R, Panarelli W, De Santo NG. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med. 1998 Sep 28;158(17):1933-9. doi: 10.1001/archinte.158.17.1933.</citation>
    <PMID>9759691</PMID>
  </reference>
  <reference>
    <citation>Laurenzi M, Cirillo M, Panarelli W, Trevisan M, Stamler R, Dyer AR, Stamler J. Baseline sodium-lithium countertransport and 6-year incidence of hypertension. The Gubbio Population Study. Circulation. 1997 Feb 4;95(3):581-7. doi: 10.1161/01.cir.95.3.581.</citation>
    <PMID>9024143</PMID>
  </reference>
  <reference>
    <citation>Cirillo M, Laurenzi M, Panarelli W, Trevisan M, Dyer AR, Stamler R, Stamler J. Sodium-lithium countertransport and blood pressure change over time: the Gubbio study. Hypertension. 1996 Jun;27(6):1305-11. doi: 10.1161/01.hyp.27.6.1305. Erratum In: Hypertension 1996 Nov;28(5):919.</citation>
    <PMID>8641740</PMID>
  </reference>
  <verification_date>June 2000</verification_date>
  <study_first_submitted>May 25, 2000</study_first_submitted>
  <study_first_submitted_qc>May 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2000</study_first_posted>
  <last_update_submitted>March 15, 2016</last_update_submitted>
  <last_update_submitted_qc>March 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2016</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

